Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Eppendorf Launches New Mastercycler nexus X2

Published: Friday, March 14, 2014
Last Updated: Thursday, March 13, 2014
Bookmark and Share
Provides solution for simultaneous PCR runs.

Eppendorf has launched the latest offering in its range of molecular biology instruments. The new Mastercycler nexus X2 is ideal for researchers looking to carry out two runs of PCR simultaneously, without any compromise on the number of samples.

The instrument comprises of two asymmetric blocks, consisting of 64 and 32 wells, which can be programmed and run completely independently, enabling two separate PCR protocols to be run in parallel.

With reduced noise emission (< 40 dB), low power consumption and a small, well-designed footprint, the Mastercycler nexus X2 is perfectly suited for use in busy academic laboratories, or any institution with multiple users or large research groups.

In comparison to other dual block cyclers, it provides an elegant solution for users wishing to run procedures using a large number of samples, without taking up a large amount of bench space.

“Many of our customers have expressed a need for a multi-block cycler that can accommodate more than 48 samples in a single block,” said Dr. Kay Körner, Global Senior Product Manager of PCR at Eppendorf.

Dr. Körner continued, “In response to this, we developed the Mastercycler nexus X2’s asymmetric block. In nature, functional asymmetry is a well known phenomenon - we are confident it will also work in a lab.”

As the latest addition to the popular Mastercycler range, the Mastercycler nexus X2 continues Eppendorf’s legacy of exceptional design and ease of use combined with efficiency and accuracy.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thomas Bachmann is New Chief Executive Officer of the Eppendorf Group
Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015.
Tuesday, August 04, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!